Showing 1 - 10 of 28
Background: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utility-based preferences for alternative CRC screening tests from a stated-preference discrete-choice survey of the general population and physicians in Canada and the United States. <P>Methods:...</p>
Persistent link: https://www.econbiz.de/10008558602
Responses of inattentive or inconsistent subjects in stated-choice (SC) surveys can lead to imprecise or biased estimates. Several SC studies have investigated inconsistency and most of these studies dropped subjects who were inconsistent. However, none of these studies reported who is more...
Persistent link: https://www.econbiz.de/10008497514
Subjects with rheumatoid arthritis (RA) enrolled in an online panel were asked to evaluate pairs of treatment alternatives with different attributes. Half of the sample saw a cheap-talk text. Preference parameters were estimated using random-parameters logit models to account for unobserved...
Persistent link: https://www.econbiz.de/10008521187
Persistent link: https://www.econbiz.de/10005719928
Persistent link: https://www.econbiz.de/10011918889
Persistent link: https://www.econbiz.de/10011570651
The transfer study, a technique used in cost-benefit analysis, is an increasingly important tool used by government agencies to assess environmental regulatory policy. This innovative book develops protocols for using the transfer method to approach environmental problems and introduces several...
Persistent link: https://www.econbiz.de/10014473959
Persistent link: https://www.econbiz.de/10012632729
In conjoint analysis (CA) studies, choosing between scenarios with multiple health attributes may be demanding for respondents. This study examined whether simplifying the choice task in CA designs, by using a design with more overlap of attribute levels, provides advantages over standard...
Persistent link: https://www.econbiz.de/10005442693
Decisions regarding the development, regulation, sale, and utilization of pharmaceutical and medical interventions require an evaluation of the balance between benefits and risks. Such evaluations are subject to two fundamental challenges—measuring the clinical effectiveness and harms...
Persistent link: https://www.econbiz.de/10011000710